Cargando…

A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma

OBJECTIVE: Hepatocellular carcinoma (HCC) has become the second most common tumor type that contributes to cancer‐related death worldwide. The study aimed to establish a robust immune‐related gene pair (IRGP) signature for predicting the prognosis of HCC patients. METHODS: Two RNA‐seq datasets (The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiao‐Yan, Yu, Shi‐Zhe, Zhang, Hua‐Peng, Li, Jie, Guo, Wen‐Zhi, Zhang, Shui‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163092/ https://www.ncbi.nlm.nih.gov/pubmed/32068352 http://dx.doi.org/10.1002/cam4.2921

Ejemplares similares

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
por: Shi, Ji‐Hua, et al.
Publicado: (2019)

Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Circ‐SPECC1 modulates TGFβ2 and autophagy under oxidative stress by sponging miR‐33a to promote hepatocellular carcinoma tumorigenesis
por: Zhang, Bin, et al.
Publicado: (2020)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
por: Sui, Jing, et al.
Publicado: (2018)

Construction of immune‐related risk signature for renal papillary cell carcinoma
por: Wang, Zhongyu, et al.
Publicado: (2018)

Signature based on metabolic‐related gene pairs can predict overall survival of osteosarcoma patients
por: Li, Long‐Qing, et al.
Publicado: (2021)

Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma
por: Han, Ke‐qi, et al.
Publicado: (2016)

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production
por: Zhang, Shuai, et al.
Publicado: (2021)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Overactivated neddylation pathway in human hepatocellular carcinoma
por: Yu, Jian, et al.
Publicado: (2018)

The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma
por: Zhang, Xuan, et al.
Publicado: (2017)

The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2022)

Sp2 promotes invasion and metastasis of hepatocellular carcinoma by targeting TRIB3 protein
por: Zhu, Yue, et al.
Publicado: (2020)

Circular RNAs in hepatocellular carcinoma: Functions and implications
por: Fu, Liyun, et al.
Publicado: (2018)

MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
por: Xu, Fei, et al.
Publicado: (2017)

Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25‐gene prognostic signatures model
por: Liu, Yushan, et al.
Publicado: (2021)

PTTG1 is involved in TNF‐α‐related hepatocellular carcinoma via the induction of c‐myc
por: Lin, Xianyi, et al.
Publicado: (2019)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells
por: Liao, Bo, et al.
Publicado: (2017)

Identification of a six‐gene signature with prognostic value for patients with endometrial carcinoma
por: Wang, Yizi, et al.
Publicado: (2018)

BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway
por: Qiu, Jiannan, et al.
Publicado: (2020)

Angiogenesis enhanced by treatment damage to hepatocellular carcinoma through the release of GDF15
por: Dong, Gang, et al.
Publicado: (2018)

Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma
por: Zhou, Xiaohan, et al.
Publicado: (2021)

Focal adhesion kinase activation limits efficacy of Dasatinib in c‐Myc driven hepatocellular carcinoma
por: Liu, Xianqiong, et al.
Publicado: (2018)

Mutational signatures and the genomic landscape of betel quid chewing‐associated tongue carcinoma
por: Zhang, Weilong, et al.
Publicado: (2019)

Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
por: Wu, Liwei, et al.
Publicado: (2019)

An immune‐related prognostic signature for predicting breast cancer recurrence
por: Tian, Zelin, et al.
Publicado: (2020)

The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma
por: Fan, Xiaoxiao, et al.
Publicado: (2018)

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index
por: Bai, Kun‐Hao, et al.
Publicado: (2020)

A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response
por: Lyu, Xiao‐Ming, et al.
Publicado: (2018)

NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2017)

METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma
por: Lin, Ye, et al.
Publicado: (2020)

A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
por: Cui, Hongxia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fnoq5f456rivqdcmodgo0a3uki